These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30058681)

  • 1. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
    Xu QF; Tang YX; Wang X
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
    Lai XJ; Cheng HF
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
    Zou T; Wang PL; Gao Y; Liang WT
    Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
    Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
    Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
    Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling.
    He S; Zhao Y; Wang X; Deng Y; Wan Z; Yao S; Shen H
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29101241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
    Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
    Hong L; Chen W; Wu D; Wang Y
    Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
    Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
    J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
    Zhang M; Liu S; Fu C; Wang X; Zhang M; Liu G; Dai C; Gong Z; Xu H; Fu Z; Xu P; Xu J; Jia X
    Cancer Biother Radiopharm; 2019 Jun; 34(5):316-324. PubMed ID: 30892073
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway.
    Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.